<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee180387875">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">2001-05-23</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>14 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GAO-01-775T</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-775T</identifier>
<identifier type="local">P0b002ee180387875</identifier>
<identifier type="former package identifier">f:d01775t</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GAO-01-775T</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GAO-01-775T</accessId>
 <reportNumber>GAO-01-775T</reportNumber>
 <subject>Biomedical research</subject>
 <subject>Safety regulation</subject>
 <subject>Safety standards</subject>
 <subject>Ethical conduct</subject>
 <subject>Informed consent (medical law)</subject>
 <type>Testimony</type>
 <accountNo>A01073</accountNo>
 <law congress="96" isPrivate="false" number="517"></law>
 <USCode title="42">
                      <section number="262"></section>
                </USCode>
</extension>
<titleInfo>
 <title>Human Subjects Research: HHS Takes Steps to Strengthen Protections, But Concerns Remain</title>
</titleInfo>
<abstract>At the federal level the Department of Health and Human Services
(HHS) is seeking to strengthen protection of human subjects in	 
biomedical research by enhancing the visibility of its human	 
subjects protection activities, improving its monitoring of	 
compliance with relevant regulations by institutions and	 
investigators, and strengthening enforcement of those		 
regulations. HHS has also issued new guidance and is collecting  
information intended to improve oversight and monitoring at the  
institutional level. HHS activities directed at the investigator 
level consist largely of educational efforts to heighten	 
investigators&apos; awareness of and compliance with ethical policies 
and practices in conducting research. Overall, HHS&apos; actions	 
appear promising, but GAO has some concerns about the pace and	 
scope of HHS&apos; efforts to ensure the safety and protection of	 
participants in clinical trials.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-01-775T/html/GAOREPORTS-GAO-01-775T.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GAO-01-775T/pdf/GAOREPORTS-GAO-01-775T.pdf</url>
</location>
<identifier type="preferred citation">GAO-01-775T</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GAO-01-775T</url>
</location>
<note>Testimony</note>
<extension>
 <searchTitle>GAO-01-775T; Human Subjects Research: HHS Takes Steps to Strengthen Protections, But Concerns Remain;
            </searchTitle>
</extension>
<subject>
 <topic>Biomedical research</topic>
 <topic>Safety regulation</topic>
 <topic>Safety standards</topic>
 <topic>Ethical conduct</topic>
 <topic>Informed consent (medical law)</topic>
</subject>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Code</title>
  <partNumber>Title 42 Section 262</partNumber>
</titleInfo>
 <identifier type="USC citation">42 U.S.C. 262</identifier>
</relatedItem>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Public Law 517 (96th Congress)</title>
</titleInfo>
 <identifier type="public law citation">Public Law 96-517</identifier>
</relatedItem>
</mods>